| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2021 | Hutson Nancy J58 | Director | Buy | 5,000 | $3.11 | $15,525.00 | +100.0% | -0.6% | -38.5% | |
| Mar 2, 2021 | Lasezkay George M71 | CEO | Sell | 6,000 | $3.37 | $20,220.00 | -1.4% | - | - | |
| Feb 10, 2021 | Thorp Clay62 | Director | Sell | 32,873 | $4.43 | $145,627.39 | -0.9% | - | - | |
| Jan 6, 2021 | Whitmore Bradford T75 | 10% Owner | Buy | 350,750 | $2.85 | $999,988.25 | +11.0% | - | - | |
| Dec 24, 2020 | Whitmore Bradford T75 | 10% Owner | Buy | 51,195 | $1.95 | $99,896.80 | +1.6% | - | - | |
| Dec 21, 2020 | Lasezkay George M71 | CEO | Sell | 3,330 | $2.07 | $6,893.10 | -1.1% | - | - | |
| Dec 2, 2020 | Whitmore Bradford T75 | 10% Owner | Buy | 53,900 | $1.95 | $105,051.10 | +1.8% | - | - | |
| Nov 24, 2020 | Whitmore Bradford T75 | 10% Owner | Buy | 62,000 | $1.65 | $102,045.80 | +2.1% | - | - | |
| Nov 16, 2020 | Whitmore Bradford T75 | 10% Owner | Buy | 62,000 | $1.69 | $104,928.80 | +2.1% | - | - | |
| Sep 22, 2020 | Lasezkay George M71 | CEO | Sell | 13,411 | $1.59 | $21,323.49 | -4.2% | - | - |